BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 32050593)

  • 1. High Dosage Lithium Treatment Induces DNA Damage and p57
    Stampone E; Bencivenga D; Barone C; Aulitto A; Verace F; Della Ragione F; Borriello A
    Int J Mol Sci; 2020 Feb; 21(3):. PubMed ID: 32050593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histone deacetylase inhibitors upregulate p57Kip2 level by enhancing its expression through Sp1 transcription factor.
    Cucciolla V; Borriello A; Criscuolo M; Sinisi AA; Bencivenga D; Tramontano A; Scudieri AC; Oliva A; Zappia V; Della Ragione F
    Carcinogenesis; 2008 Mar; 29(3):560-7. PubMed ID: 18204075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p57(Kip2) and cancer: time for a critical appraisal.
    Borriello A; Caldarelli I; Bencivenga D; Criscuolo M; Cucciolla V; Tramontano A; Oliva A; Perrotta S; Della Ragione F
    Mol Cancer Res; 2011 Oct; 9(10):1269-84. PubMed ID: 21816904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Beckwith-Wiedemann-Associated
    Stampone E; Bencivenga D; Barone C; Di Finizio M; Della Ragione F; Borriello A
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cyclin-dependent kinase inhibitor p57Kip2 regulates cell cycle exit, differentiation, and migration of embryonic cerebral cortical precursors.
    Tury A; Mairet-Coello G; DiCicco-Bloom E
    Cereb Cortex; 2011 Aug; 21(8):1840-56. PubMed ID: 21245411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulation of the KIP family members p27(KIP1) and p57(KIP2) by SKP2 and the role of methylation in p57(KIP2) inactivation in nonsmall cell lung cancer.
    Pateras IS; Apostolopoulou K; Koutsami M; Evangelou K; Tsantoulis P; Liloglou T; Nikolaidis G; Sigala F; Kittas C; Field JK; Kotsinas A; Gorgoulis VG
    Int J Cancer; 2006 Dec; 119(11):2546-56. PubMed ID: 16988944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. P21-activated kinase 4 regulates the cyclin-dependent kinase inhibitor p57(kip2) in human breast cancer.
    Li Y; Wang D; Zhang H; Wang C; Dai W; Cheng Z; Wang G; Li F
    Anat Rec (Hoboken); 2013 Oct; 296(10):1561-7. PubMed ID: 23873832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The long non-coding RNA Kcnq1ot1 controls maternal p57 expression in muscle cells by promoting H3K27me3 accumulation to an intragenic MyoD-binding region.
    Andresini O; Rossi MN; Matteini F; Petrai S; Santini T; Maione R
    Epigenetics Chromatin; 2019 Jan; 12(1):8. PubMed ID: 30651140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic and Epigenetic Control of CDKN1C Expression: Importance in Cell Commitment and Differentiation, Tissue Homeostasis and Human Diseases.
    Stampone E; Caldarelli I; Zullo A; Bencivenga D; Mancini FP; Della Ragione F; Borriello A
    Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29614816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcriptional regulation of
    Rossi MN; Andresini O; Matteini F; Maione R
    Front Biosci (Landmark Ed); 2018 Jan; 23(1):83-108. PubMed ID: 28930539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TBX3 promotes proliferation of papillary thyroid carcinoma cells through facilitating PRC2-mediated p57
    Li X; Ruan X; Zhang P; Yu Y; Gao M; Yuan S; Zhao Z; Yang J; Zhao L
    Oncogene; 2018 May; 37(21):2773-2792. PubMed ID: 29511350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of p57kipĀ² promotes cell invasion via LIMK/cofilin pathway in human nasopharyngeal carcinoma cells.
    Chow SE; Wang JS; Lin MR; Lee CL
    J Cell Biochem; 2011 Nov; 112(11):3459-68. PubMed ID: 21769918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of multiple cell cycle regulatory functions of p57Kip2 in human T lymphocytes.
    Li G; Domenico J; Lucas JJ; Gelfand EW
    J Immunol; 2004 Aug; 173(4):2383-91. PubMed ID: 15294951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The multiple roles of the cyclin-dependent kinase inhibitory protein p57(KIP2) in cerebral cortical neurogenesis.
    Tury A; Mairet-Coello G; DiCicco-Bloom E
    Dev Neurobiol; 2012 Jun; 72(6):821-42. PubMed ID: 22076965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of p57
    Takahashi K; Yoneyama Y; Koizumi N; Utoguchi N; Kanayama N; Higashi N
    Placenta; 2021 Jan; 104():168-178. PubMed ID: 33360007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-21 inhibits p57Kip2 expression in prostate cancer.
    Mishra S; Lin CL; Huang TH; Bouamar H; Sun LZ
    Mol Cancer; 2014 Sep; 13():212. PubMed ID: 25216674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The KIP/CIP family members p21^{Waf1/Cip1} and p57^{Kip2} as diagnostic markers for breast cancer.
    Zohny SF; Baothman OA; El-Shinawi M; Al-Malki AL; Zamzami MA; Choudhry H
    Cancer Biomark; 2017; 18(4):413-423. PubMed ID: 28106536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new ubiquitin ligase involved in p57KIP2 proteolysis regulates osteoblast cell differentiation.
    Kim M; Nakamoto T; Nishimori S; Tanaka K; Chiba T
    EMBO Rep; 2008 Sep; 9(9):878-84. PubMed ID: 18660753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p57KIP2: "Kip"ing the cell under control.
    Pateras IS; Apostolopoulou K; Niforou K; Kotsinas A; Gorgoulis VG
    Mol Cancer Res; 2009 Dec; 7(12):1902-19. PubMed ID: 19934273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genome-wide expression profiling of placentas in the p57Kip2 model of pre-eclampsia.
    Knox KS; Baker JC
    Mol Hum Reprod; 2007 Apr; 13(4):251-63. PubMed ID: 17289831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.